Related Experiment Video
Updated: Dec 18, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Cytokine storm induced by SARS-CoV-2
Peipei Song1, Wei Li1, Jianqin Xie1
1Laboratory Medicine Center, Lanzhou University Second Hospital, the Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China.
The COVID-19 pandemic, caused by SARS-CoV-2, features a dangerous cytokine storm in severe cases. This review details COVID-19
Area of Science:
- * Virology and Immunology
- * Infectious Diseases
Background:
- * Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to a global health crisis with significant mortality.
- * Clinical presentations of COVID-19 are diverse, from mild symptoms to severe conditions like ARDS and death.
- * Severe COVID-19 cases are often characterized by a cytokine storm, an overactivation of the immune system.
Purpose of the Study:
- * To review the epidemiological profile of COVID-19.
- * To elucidate the molecular mechanisms of SARS-CoV-2-induced cytokine storm and immune responses.
- * To discuss pathophysiological changes, antiviral treatments, and potential cytokine-targeting therapies.
Main Methods:
- * Comprehensive literature review of current studies on COVID-19.
- * Analysis of epidemiological data and clinical case studies.
- * Examination of molecular and immunological mechanisms involved in SARS-CoV-2 infection.
Main Results:
- * The cytokine storm is a critical factor in COVID-19 progression, potentially causing multiple organ failure and death.
- * Understanding immune responses and pathophysiological changes is crucial for effective treatment.
- * Existing antiviral compounds and potential cytokine-targeting drugs offer therapeutic avenues.
Conclusions:
- * The cytokine storm is a key driver of severe COVID-19 pathology.
- * Targeting excessive immune responses is vital for improving patient outcomes.
- * Further research into antiviral and immunomodulatory therapies is essential for combating COVID-19.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Related Concept Videos
Pneumonia II: Pathophysiology
The JAK-STAT Signaling Pathway
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...